HRA licences additional rights for Esmya to PregLem for benign gynecological disorders April 13, 2010
Sanofi-aventis obtains exclusive worldwide license for new regenerative diabetes therapeutic April 9, 2010
Swedish Orphan Biovitrum and LFB launch Willfact in Germany for von Willebrand's disease April 9, 2010